Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin (2011)
- Authors:
- Cerda, Alvaro
- Genvigir, Fabiana Dalla Vecchia
- Willrich, Maria Alice Vieira
- Arazi, Simone Sorkin
- Bernik, Marcia Martins Silveira
- Dórea, Egidio Lima
- Bertolami, Marcelo Chiara - Instituto Dante Pazzanese de Cardiologia (IDPC)
- Faludi, André Arpad - Instituto Dante Pazzanese de Cardiologia (IDPC)
- Hirata, Mario Hiroyuki
- Hirata, Rosario Dominguez Crespo
- USP affiliated authors: HIRATA, MARIO HIROYUKI - FCF ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF ; DOREA, EGIDIO LIMA - HU
- Unidades: FCF; HU
- DOI: 10.1186/1476-511X-10-206
- Subjects: APOLIPOPROTEÍNAS; HIPERCOLESTEROLEMIA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Lipids in Health and Disease
- ISSN: 1476-511X
- Volume/Número/Paginação/Ano: v. 10, art. 206, p. 1-11, 2011
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
CERDA, Alvaro et al. Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin. Lipids in Health and Disease, v. 10, p. 1-11, 2011Tradução . . Disponível em: https://doi.org/10.1186/1476-511X-10-206. Acesso em: 19 abr. 2024. -
APA
Cerda, A., Genvigir, F. D. V., Willrich, M. A. V., Arazi, S. S., Bernik, M. M. S., Dórea, E. L., et al. (2011). Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin. Lipids in Health and Disease, 10, 1-11. doi:10.1186/1476-511X-10-206 -
NLM
Cerda A, Genvigir FDV, Willrich MAV, Arazi SS, Bernik MMS, Dórea EL, Bertolami MC, Faludi AA, Hirata MH, Hirata RDC. Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin [Internet]. Lipids in Health and Disease. 2011 ; 10 1-11.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1186/1476-511X-10-206 -
Vancouver
Cerda A, Genvigir FDV, Willrich MAV, Arazi SS, Bernik MMS, Dórea EL, Bertolami MC, Faludi AA, Hirata MH, Hirata RDC. Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin [Internet]. Lipids in Health and Disease. 2011 ; 10 1-11.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1186/1476-511X-10-206 - Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals
- Differentiation of african components of ancestry to stratify groups in a case-control study of a brazilian urban population
- Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response
- Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin
- Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression
- The contribution of genetic polymorphisms in 60 candidate genes to variability in atorvastatin response
- CYP3A5*3A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia
- Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients
- Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response
- Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression
Informações sobre o DOI: 10.1186/1476-511X-10-206 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
